Accessibility Menu
PetMed Express Stock Quote

PetMed Express (NASDAQ: PETS)

$2.92
(10.2%)
+0.27
Price as of October 22, 2025, 3:53 p.m. ET

KEY DATA POINTS

Current Price
$2.9
Daily Change
(10.2%) +$0.27
Day's Range
$2.57 - $2.97
Previous Close
$2.9
Open
$2.68
Beta
0.75
Volume
450,957
Average Volume
127,544
Market Cap
60.9M
Market Cap / Employee
$2.90M
52wk Range
$2.42 - $6.85
Revenue
-
Gross Margin
0.27%
Dividend Yield
N/A
EPS
-$0.31
CAPs Rating
-
Industry
Specialty Retail

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

PetMed Express Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
PETS-29.27%-88.89%-35.56%+364%
S&P+14.5%+93.32%+14.09%+608%

PetMed Express Company Info

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.

News & Analysis

The Fool has written over 100 articles on PetMed Express.

Financial Health

General

Q1 2025YOY Change
Revenue$46.47M-30.1%
Gross Profit$16.87M3.6%
Gross Margin36.31%11.8%
Market Cap$86.55M-14.6%
Market Cap / Employee$0.50M0.0%
Employees173-39.7%
Net Income-$11.64M-132.1%
EBITDA-$1.25M38.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q1 2025YOY Change
Net Cash$54.72M-1.0%
Accounts Receivable$2.32M-29.4%
Inventory16.2-43.3%

Liabilities

Q1 2025YOY Change
Long Term Debt$0.54M-46.2%
Short Term Debt$0.46M0.4%

Ratios

Q1 2025YOY Change
Return On Assets-3.87%0.3%
Return On Invested Capital10.68%-7.1%

Cash Flow

Q1 2025YOY Change
Free Cash Flow$4.62M-21.3%
Operating Free Cash Flow$7.01M-1.6%

Valuation

MetricQ4 2024YoY Change
Price to Earnings450.47-
Price to Book0.890.791.030.90-11.17%
Price to Sales0.310.300.400.389.45%
Price to Tangible Book Value1.461.281.671.45-11.86%
Price to Free Cash Flow TTM150.24-
Enterprise Value to EBITDA6.5711.8643.47-26.2521.45%
Free Cash Flow Yield0.7%-
Return on Equity-2.4%-1.0%0.4%-6.9%5.39%
Total Debt$1.32M$1.21M$1.11M$1.00M-31.50%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.